The Effect of Docosahexaenoic Acid Supplementation on Biomarkers of Concussion Over the Course of a Year in Canadian National Rugby Players

Texas Christian University

Status: Completed

Conditions: Head Trauma

Treatments: Dietary Supplement: Docosahexaenoic Acid (DHA)

Study type: Interventional

Funder types: Other

Identifiers

NCT03582267

1706-066-1706

Details and patient eligibility

About

Nutrition interventions may present a safe and relatively risk free intervention for protection against subconcussive impacts. Docosahexaenoic acid (DHA, 22:6n-3) is the principal Omega 3 polyunsaturated fatty acid in the brain, playing an integral role in the brain's development and structural integrity. The goal of this study is to determine if supplementation with DHA attenuates blood biomarkers of repetitive head trauma linked to sub-concussive impacts sustained in rugby participation.

Enrollment: 50 patients

Sex: All

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Canadian national rugby athletes on 7s and 15s teams

Exclusion criteria

• None

Trial design

Primary purpose: Basic Science

Allocation: Non-Randomized

Interventional model: Crossover Assignment

Masking: None (Open label)

---

50 participants in 2 patient groups

Dietary Supplement

Experimental group

Description:

Docosahexaenoic Acid (DHA)

Treatment:

Dietary Supplement: Docosahexaenoic Acid (DHA)

No Intervention

No Intervention group

Description:

No Docosahexaenoic Acid supplementation